Clostridium difficile Infection and Treatment (Q166695): Difference between revisions

From geokb
(‎Changed label, description and/or aliases in en, and other parts: removed Epidemiology from aliases)
(‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1)
description / endescription / en
This cluster of papers focuses on the epidemiology, treatment, and prevention of Clostridium difficile infection, with a particular emphasis on fecal microbiota transplantation, antibiotic-associated diarrhea, healthcare-associated infections, toxin
Study of C. difficile infections & treatments: epidemiology, prevention, treatment options, and microbiome diversity.

Revision as of 13:12, 30 August 2024

Study of C. difficile infections & treatments: epidemiology, prevention, treatment options, and microbiome diversity.
  • Fecal Microbiota Transplantation
  • Antibiotic-Associated Diarrhea
  • Healthcare-Associated Infections
  • Toxin Production
  • Clinical Practice Guidelines
  • Microbiome Diversity
  • Vancomycin and Metronidazole Treatment
  • Risk Factors
  • Bacterial Toxins
Language Label Description Also known as
English
Clostridium difficile Infection and Treatment
Study of C. difficile infections & treatments: epidemiology, prevention, treatment options, and microbiome diversity.
  • Fecal Microbiota Transplantation
  • Antibiotic-Associated Diarrhea
  • Healthcare-Associated Infections
  • Toxin Production
  • Clinical Practice Guidelines
  • Microbiome Diversity
  • Vancomycin and Metronidazole Treatment
  • Risk Factors
  • Bacterial Toxins

Statements